The Trentonian

DCN Dx Acquires Point-Of-Care Diagnostics Development Company PortaScience

MOORESTOWN, N.J., June 17, 2021 /PRNewswire/ — DCN Dx, an international provider of point-of-care diagnostics development, products, and educational programming, today announced it has completed its ...
Seeking Alpha

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

SALT LAKE CITY, Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...
Business Wire

SYNAPS Dx DISCERN Provides First-to-Market Definitive Diagnostic Test for Alzheimer’s Disease, Supports Payer Treatment Decisions, Releases Paper Authored by Advisory Council

ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative disorders and conditions, ...
Nasdaq

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

SALT LAKE CITY, Dec. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...
Yahoo Finance

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

SALT LAKE CITY, April 14, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...